Anti-Human IL23R Polyclonal Antibody from ProteoGenix; catalogue ARO-A22074; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-Human IL23R Polyclonal Antibody: Unlocking the Potential of IL23R Research
As a leading provider of biotech products, we are proud to introduce our Anti-Human IL23R Polyclonal Antibody. This powerful antibody is specifically designed to target and detect the Interleukin-23 receptor (IL23R), a crucial protein involved in the regulation of immune responses. With its high specificity and sensitivity, this antibody is an essential tool for researchers studying the role of IL23R in various biological processes.
IL23R is a transmembrane protein that belongs to the IL-12 receptor family. It is primarily expressed on the surface of immune cells, such as T cells and natural killer cells, and plays a critical role in the activation and differentiation of these cells. IL23R is a key mediator of the pro-inflammatory cytokine IL-23, which is involved in the pathogenesis of various autoimmune and inflammatory diseases.
Our Anti-Human IL23R Polyclonal Antibody is suitable for a wide range of applications, including Western blotting, immunohistochemistry, and flow cytometry. It has been validated for use in both human and animal samples, making it a versatile tool for researchers in different fields.
– Inflammatory Bowel Disease (IBD) Research: IL23R has been identified as a risk gene for IBD, and our antibody can be used to study its expression and function in the gut tissue of patients with Crohn’s disease and ulcerative colitis.
– Cancer Immunotherapy: IL23R has been shown to play a role in anti-tumor immune responses, and our antibody can be used to investigate its potential as a therapeutic target for cancer immunotherapy.
– Autoimmune Disease Research: IL23R has been implicated in various autoimmune diseases, such as psoriasis and rheumatoid arthritis. Our antibody can aid in the study of its role in these conditions and potentially lead to the development of new treatments.
Our Anti-Human IL23R Polyclonal Antibody is a highly specific and sensitive tool for detecting IL23R in various research applications. It is suitable for use in Western blotting, immunohistochemistry, and flow cytometry, making it a versatile choice for researchers studying the role of IL23R in diseases such as IBD, cancer, and autoimmune disorders.
Structure:
–
Brief overview of the antibody and its target, IL23R.
–
Explanation of IL23R’s role in immune responses and its association with IL-23.
–
Description of the different techniques in which the antibody can be used.
–
Examples of how the antibody can be applied in specific research areas.
– Emphasis on the antibody’s specificity, sensitivity, and versatility.
– Conclusion: Summary of the key features and benefits of our Anti-Human IL23R Polyclonal Antibody.
In conclusion, our Anti-Human IL23R Polyclonal Antibody is a valuable tool for researchers studying IL23R and its role in various diseases. With its high specificity and sensitivity, it can aid in the advancement of scientific knowledge and potentially lead to the development of new treatments. Choose our antibody to unlock the potential of your IL23R research today.
ProteoGenix catalogue number ARO-A22074. For research use only.
Target: Interleukin-23 receptor; IL-23 receptor; IL-23R; IL23R; Clonality: Polyclonal Antibody; Reactivity: Human; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
